A Phase I Study of TRN501 in Healthy Volunteers

NCT06453551 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: TRN501 - Dose 1
DRUG: TRN501 - Dose 2
DRUG: TRN501 - Dose 3
DRUG: TRN501 - Dose 4
DRUG: TRN501 - Dose 5
DRUG: TRN501 - Dose 6
DRUG: TRN501 - Dose 7
DRUG: TRN501 - Dose 8

Sponsor

SNLD, Ltd.